Drug pricing and control of health expenditures: a comparison between a proportional decision rule and a cost‐per‐QALY rule

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1751|30|4|395-402

ISSN： 0749-6753

Source： International Journal Of Health Planning And Management, Vol.30, Iss.4, 2015-10, pp. : 395-402

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Graphic Rule for Drug Metabolism Systems

By  

Current Drug Metabolism, Vol. 11, Iss. 4, 2010-05 ,pp. : 369-378

Bentham Science Publishers

Access to resources Recommend Favorite

Going further than Lipinski's rule in drug design

By Walters W Patrick  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 2, 2012-02 ,pp. : 99-107

Informa Healthcare

Access to resources Recommend Favorite

Reform of Prescription Drug Reimbursement and Pricing in the German Social Health Insurance Market: A Comparison of Three Scenarios

By Greß Stefan  

PharmacoEconomics, Vol. 25, Iss. 6, 2007-01 ,pp. : 443-454

Adis International

Access to resources Recommend Favorite

Debate over FDA drug approval using new `animal rule'

By  

Inpharma, Vol. 1, Iss. 1379, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Quantification of the Potential Impact of Cost-effectiveness Thresholds on Dutch Drug Expenditures Using Retrospective Analysis

By Boersma Cornelis   Broere Adriaan   Postma Maarten J.  

Value in Health, Vol. 13, Iss. 6, 2010-09 ,pp. : 853-856

Blackwell Publishing

Access to resources Recommend Favorite